Carsten Nieder1,2, Kristian S Imingen3,2. 1. Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway; carsten.nieder@nlsh.no. 2. Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway. 3. Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway.
Abstract
BACKGROUND/AIM: Recent studies suggested that high unintended radiation doses to the heart may reduce survival of patients with non-small-cell lung cancer (NSCLC) irradiated with curative intent. In the palliative setting, limited information is available. Therefore, we analyzed a single-institution cohort of 165 patients. PATIENTS AND METHODS: Patients in this retrospective study received palliative (chemo)radiotherapy (at least 30 Gy). Typical radiation doses were 10-13 fractions of 3 Gy and 15 fractions of 2.8 Gy. Heart dose constraints were not employed during treatment planning. The maximum dose to 1 cc of the heart was registered and converted into the equivalent dose in 2-Gy fractions (EQD2). RESULTS: The median heart dose (maximum to 1 cc) was 26 Gy (range=11-42 Gy). This dose corresponded to 28-108% of the prescription dose. After conversion into EQD2, the median maximum heart dose to 1 cc was 26 Gy, range=10-58 Gy). Neither higher T-stage nor higher N-stage predicted for higher maximum heart EQD2. The maximum heart EQD2 was not associated with overall survival. CONCLUSION: The current practice of focusing on sparing of lungs and esophagus appears acceptable in the context of palliative regimes. To further strengthen this strategy, additional studies looking at cardiac substructures and other dosimetric variables such as mean dose are warranted. Copyright
BACKGROUND/AIM: Recent studies suggested that high unintended radiation doses to the heart may reduce survival of patients with non-small-cell lung cancer (NSCLC) irradiated with curative intent. In the palliative setting, limited information is available. Therefore, we analyzed a single-institution cohort of 165 patients. PATIENTS AND METHODS: Patients in this retrospective study received palliative (chemo)radiotherapy (at least 30 Gy). Typical radiation doses were 10-13 fractions of 3 Gy and 15 fractions of 2.8 Gy. Heart dose constraints were not employed during treatment planning. The maximum dose to 1 cc of the heart was registered and converted into the equivalent dose in 2-Gy fractions (EQD2). RESULTS: The median heart dose (maximum to 1 cc) was 26 Gy (range=11-42 Gy). This dose corresponded to 28-108% of the prescription dose. After conversion into EQD2, the median maximum heart dose to 1 cc was 26 Gy, range=10-58 Gy). Neither higher T-stage nor higher N-stage predicted for higher maximum heart EQD2. The maximum heart EQD2 was not associated with overall survival. CONCLUSION: The current practice of focusing on sparing of lungs and esophagus appears acceptable in the context of palliative regimes. To further strengthen this strategy, additional studies looking at cardiac substructures and other dosimetric variables such as mean dose are warranted. Copyright
Authors: Hans Paul van der Laan; R Melissa Anakotta; Erik W Korevaar; Margriet Dieters; J Fred Ubbels; Robin Wijsman; Nanna M Sijtsema; Stefan Both; Johannes A Langendijk; Christina T Muijs; Antje C Knopf Journal: Acta Oncol Date: 2019-09-26 Impact factor: 4.089
Authors: Marian Reinfuss; Anna Mucha-Małecka; Tomasz Walasek; Paweł Blecharz; Jerzy Jakubowicz; Piotr Skotnicki; Teresa Kowalska Journal: Lung Cancer Date: 2010-07-31 Impact factor: 5.705
Authors: Katelyn M Atkins; Bhupendra Rawal; Tafadzwa L Chaunzwa; Nayan Lamba; Danielle S Bitterman; Christopher L Williams; David E Kozono; Elizabeth H Baldini; Aileen B Chen; Paul L Nguyen; Anthony V D'Amico; Anju Nohria; Udo Hoffmann; Hugo J W L Aerts; Raymond H Mak Journal: J Am Coll Cardiol Date: 2019-06-18 Impact factor: 24.094
Authors: U Nestle; C Nieder; K Walter; U Abel; D Ukena; G W Sybrecht; K Schnabel Journal: Int J Radiat Oncol Biol Phys Date: 2000-08-01 Impact factor: 7.038
Authors: Alexander N Hanania; Walker Mainwaring; Yohannes T Ghebre; Nicola A Hanania; Michelle Ludwig Journal: Chest Date: 2019-04-15 Impact factor: 9.410